Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 87 Pages
Report ld: 4514321
Request Sample
Customized Report
Recombinant Mussel Mucin Market Size(US$)

CAGR 2025-2031
9.4%
Market Size,2031
USD 89.8
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Recombinant Mussel Mucin was valued at US$ 48.3 million in the year 2024 and is projected to reach a revised size of US$ 89.8 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
North American market for Recombinant Mussel Mucin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Mussel Mucin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Mussel Mucin include Kollodis BioSciences, JUYOU, PAML Biotechnology, Hangzhou Jiedi Biotechnology Co., Ltd., Jiangsu Jinpu Noan Biotechnology Co., Ltd., BD, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Recombinant Mussel Mucin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Mussel Mucin.
The Recombinant Mussel Mucin market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Mussel Mucin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Mussel Mucin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Mussel Mucin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Recombinant Mussel Mucin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Recombinant Mussel Mucin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Recombinant Mussel Mucin Market Overview
1.1 Product Definition
1.2 Recombinant Mussel Mucin by Type
1.2.1 Global Recombinant Mussel Mucin Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Recombinant Mussel Mucin type I
1.2.3 Recombinant Mussel Mucin type II
1.2.4 Recombinant Mussel Mucin type III
1.2.5 Recombinant Mussel Mucin type V
1.3 Recombinant Mussel Mucin by Application
1.3.1 Global Recombinant Mussel Mucin Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medical Bioadhesives
1.3.3 Wound Healing Materials
1.3.4 Medical and Beauty Field
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Recombinant Mussel Mucin Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Recombinant Mussel Mucin Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Recombinant Mussel Mucin Production Estimates and Forecasts (2020-2031)
1.4.4 Global Recombinant Mussel Mucin Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Recombinant Mussel Mucin Production Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Mussel Mucin Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Recombinant Mussel Mucin, Industry Ranking, 2023 VS 2024
2.4 Global Recombinant Mussel Mucin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Recombinant Mussel Mucin Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Recombinant Mussel Mucin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Recombinant Mussel Mucin, Product Offered and Application
2.8 Global Key Manufacturers of Recombinant Mussel Mucin, Date of Enter into This Industry
2.9 Recombinant Mussel Mucin Market Competitive Situation and Trends
2.9.1 Recombinant Mussel Mucin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Recombinant Mussel Mucin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Recombinant Mussel Mucin Production by Region
3.1 Global Recombinant Mussel Mucin Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Recombinant Mussel Mucin Production Value by Region (2020-2031)
3.2.1 Global Recombinant Mussel Mucin Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Recombinant Mussel Mucin by Region (2026-2031)
3.3 Global Recombinant Mussel Mucin Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Recombinant Mussel Mucin Production Volume by Region (2020-2031)
3.4.1 Global Recombinant Mussel Mucin Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Recombinant Mussel Mucin by Region (2026-2031)
3.5 Global Recombinant Mussel Mucin Market Price Analysis by Region (2020-2025)
3.6 Global Recombinant Mussel Mucin Production and Value, Year-over-Year Growth
3.6.1 North America Recombinant Mussel Mucin Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Recombinant Mussel Mucin Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Recombinant Mussel Mucin Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Recombinant Mussel Mucin Production Value Estimates and Forecasts (2020-2031)
4 Recombinant Mussel Mucin Consumption by Region
4.1 Global Recombinant Mussel Mucin Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Recombinant Mussel Mucin Consumption by Region (2020-2031)
4.2.1 Global Recombinant Mussel Mucin Consumption by Region (2020-2025)
4.2.2 Global Recombinant Mussel Mucin Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Recombinant Mussel Mucin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Recombinant Mussel Mucin Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Recombinant Mussel Mucin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Recombinant Mussel Mucin Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Recombinant Mussel Mucin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Recombinant Mussel Mucin Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Recombinant Mussel Mucin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Recombinant Mussel Mucin Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Recombinant Mussel Mucin Production by Type (2020-2031)
5.1.1 Global Recombinant Mussel Mucin Production by Type (2020-2025)
5.1.2 Global Recombinant Mussel Mucin Production by Type (2026-2031)
5.1.3 Global Recombinant Mussel Mucin Production Market Share by Type (2020-2031)
5.2 Global Recombinant Mussel Mucin Production Value by Type (2020-2031)
5.2.1 Global Recombinant Mussel Mucin Production Value by Type (2020-2025)
5.2.2 Global Recombinant Mussel Mucin Production Value by Type (2026-2031)
5.2.3 Global Recombinant Mussel Mucin Production Value Market Share by Type (2020-2031)
5.3 Global Recombinant Mussel Mucin Price by Type (2020-2031)
6 Segment by Application
6.1 Global Recombinant Mussel Mucin Production by Application (2020-2031)
6.1.1 Global Recombinant Mussel Mucin Production by Application (2020-2025)
6.1.2 Global Recombinant Mussel Mucin Production by Application (2026-2031)
6.1.3 Global Recombinant Mussel Mucin Production Market Share by Application (2020-2031)
6.2 Global Recombinant Mussel Mucin Production Value by Application (2020-2031)
6.2.1 Global Recombinant Mussel Mucin Production Value by Application (2020-2025)
6.2.2 Global Recombinant Mussel Mucin Production Value by Application (2026-2031)
6.2.3 Global Recombinant Mussel Mucin Production Value Market Share by Application (2020-2031)
6.3 Global Recombinant Mussel Mucin Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Kollodis BioSciences
7.1.1 Kollodis BioSciences Recombinant Mussel Mucin Company Information
7.1.2 Kollodis BioSciences Recombinant Mussel Mucin Product Portfolio
7.1.3 Kollodis BioSciences Recombinant Mussel Mucin Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Kollodis BioSciences Main Business and Markets Served
7.1.5 Kollodis BioSciences Recent Developments/Updates
7.2 JUYOU
7.2.1 JUYOU Recombinant Mussel Mucin Company Information
7.2.2 JUYOU Recombinant Mussel Mucin Product Portfolio
7.2.3 JUYOU Recombinant Mussel Mucin Production, Value, Price and Gross Margin (2020-2025)
7.2.4 JUYOU Main Business and Markets Served
7.2.5 JUYOU Recent Developments/Updates
7.3 PAML Biotechnology
7.3.1 PAML Biotechnology Recombinant Mussel Mucin Company Information
7.3.2 PAML Biotechnology Recombinant Mussel Mucin Product Portfolio
7.3.3 PAML Biotechnology Recombinant Mussel Mucin Production, Value, Price and Gross Margin (2020-2025)
7.3.4 PAML Biotechnology Main Business and Markets Served
7.3.5 PAML Biotechnology Recent Developments/Updates
7.4 Hangzhou Jiedi Biotechnology Co., Ltd.
7.4.1 Hangzhou Jiedi Biotechnology Co., Ltd. Recombinant Mussel Mucin Company Information
7.4.2 Hangzhou Jiedi Biotechnology Co., Ltd. Recombinant Mussel Mucin Product Portfolio
7.4.3 Hangzhou Jiedi Biotechnology Co., Ltd. Recombinant Mussel Mucin Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Hangzhou Jiedi Biotechnology Co., Ltd. Main Business and Markets Served
7.4.5 Hangzhou Jiedi Biotechnology Co., Ltd. Recent Developments/Updates
7.5 Jiangsu Jinpu Noan Biotechnology Co., Ltd.
7.5.1 Jiangsu Jinpu Noan Biotechnology Co., Ltd. Recombinant Mussel Mucin Company Information
7.5.2 Jiangsu Jinpu Noan Biotechnology Co., Ltd. Recombinant Mussel Mucin Product Portfolio
7.5.3 Jiangsu Jinpu Noan Biotechnology Co., Ltd. Recombinant Mussel Mucin Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Jiangsu Jinpu Noan Biotechnology Co., Ltd. Main Business and Markets Served
7.5.5 Jiangsu Jinpu Noan Biotechnology Co., Ltd. Recent Developments/Updates
7.6 BD
7.6.1 BD Recombinant Mussel Mucin Company Information
7.6.2 BD Recombinant Mussel Mucin Product Portfolio
7.6.3 BD Recombinant Mussel Mucin Production, Value, Price and Gross Margin (2020-2025)
7.6.4 BD Main Business and Markets Served
7.6.5 BD Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Mussel Mucin Industry Chain Analysis
8.2 Recombinant Mussel Mucin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Recombinant Mussel Mucin Production Mode & Process Analysis
8.4 Recombinant Mussel Mucin Sales and Marketing
8.4.1 Recombinant Mussel Mucin Sales Channels
8.4.2 Recombinant Mussel Mucin Distributors
8.5 Recombinant Mussel Mucin Customer Analysis
9 Recombinant Mussel Mucin Market Dynamics
9.1 Recombinant Mussel Mucin Industry Trends
9.2 Recombinant Mussel Mucin Market Drivers
9.3 Recombinant Mussel Mucin Market Challenges
9.4 Recombinant Mussel Mucin Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Recombinant Mussel Mucin market is projected to grow from US$ 52.39 million in 2025 to US$ 97 million by 2032, at a CAGR of 9.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 147
USD 4900.00
(Single User License)
The global Recombinant Mussel Mucin market size was US$ 52.39 million in 2025 and is forecast to reach a readjusted size of US$ 97 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 79
USD 4250.00
(Single User License)
The global market for Recombinant Mussel Mucin was estimated to be worth US$ 52.39 million in 2025 and is projected to reach US$ 97 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 109
USD 3950.00
(Single User License)
The global Recombinant Mussel Mucin market was valued at US$ 52.39 million in 2025 and is anticipated to reach US$ 97 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 132
USD 2900.00
(Single User License)
The global Recombinant Mussel Mucin market is projected to grow from US$ 48.3 million in 2024 to US$ 89.8 million by 2031, at a CAGR of 9.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 131
USD 4900.00
(Single User License)
The global Recombinant Mussel Mucin market size was US$ 48.3 million in 2024 and is forecast to a readjusted size of US$ 89.8 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 77
USD 4250.00
(Single User License)
The global market for Recombinant Mussel Mucin was estimated to be worth US$ 48.3 million in 2024 and is forecast to a readjusted size of US$ 89.8 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 98
USD 3950.00
(Single User License)
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
Published Date: 2024-10-11
Pages: 105
USD 4350.00
(Single User License)
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
Published Date: 2024-10-11
Pages: 86
USD 2900.00
(Single User License)
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
Published Date: 2024-10-11
Pages: 146
USD 4900.00
(Single User License)
The global Recombinant Mussel Mucin market is projected to grow from US$ 52.39 million in 2025 to US$ 97 million by 2032, at a CAGR of 9.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 147
The global Recombinant Mussel Mucin market size was US$ 52.39 million in 2025 and is forecast to reach a readjusted size of US$ 97 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 79
The global market for Recombinant Mussel Mucin was estimated to be worth US$ 52.39 million in 2025 and is projected to reach US$ 97 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-01-09
Pages: 109
The global Recombinant Mussel Mucin market was valued at US$ 52.39 million in 2025 and is anticipated to reach US$ 97 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-01-09
Pages: 132
The global Recombinant Mussel Mucin market is projected to grow from US$ 48.3 million in 2024 to US$ 89.8 million by 2031, at a CAGR of 9.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 131
The global Recombinant Mussel Mucin market size was US$ 48.3 million in 2024 and is forecast to a readjusted size of US$ 89.8 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 77
The global market for Recombinant Mussel Mucin was estimated to be worth US$ 48.3 million in 2024 and is forecast to a readjusted size of US$ 89.8 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 98
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
Published: 2024-10-11
Pages: 105
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
Published: 2024-10-11
Pages: 86
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
Published: 2024-10-11
Pages: 146
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now